Table of Contents Table of Contents
Previous Page  87 / 242 Next Page
Show Menu
Previous Page 87 / 242 Next Page
Page Background

87

MIDAZOLAM/FENTANYL, PROPOFOL/ALFENTANIL OR ALFENTANIL ONLY FOR COLONOSCOPY

7

After colonoscopy and before discharge, patients and gastroenterologists filled in validated

questionnaires modified and translated from the Patient Satisfaction with Sedation

Instrument (PSSI)

11

and Clinician Satisfaction with Sedation Instrument (CSSI),

11

respectively,

whichprovide feasible and valid assessment of procedural sedation satisfaction inoutpatient

colonoscopy with 4 subscores for patient`s and 3 subscores for endoscopist`s satisfaction.

11

Subscores for the PSSI contain questions on sedation delivery, procedural recall, sedation

side effects, and global satisfaction.

Subscores for the CSSI refer to corresponding issues among gastroenterologists: sedation

administration, recovery, as well as post-procedural and global satisfaction. Both groups

could classify their (dis)satisfaction during the procedure ranging from 1 = very satisfied,

2 = satisfied, 3 = somewhat satisfied, 4 = neither satisfied nor dissatisfied, 5 = somewhat

dissatisfied, 6 = dissatisfied to 7 = very dissatisfied.

Monitoring

After assessment of baseline data, an intravenous line was inserted, and patients were

prepared for the procedure. During colonoscopy, patients were monitored with three-lead

electrocardiogram (ECG), non-invasive blood pressure (NIBP), pulse oximetry (SpO

2

), and

end-tidal capnography (etCO

2

), documented at 5-min intervals. Heart rate (HR) was derived

both from the ECG and pulse oximetry. Two l/min of oxygen was given via a nasal cannula

from the start of sedation.

Team activities were observed by a trained medical student without clinical experience

regarding sedation, using a four-channel remote video system, which did not only provide

a wide angle overview of the sedation room, but also recorded time-synchronised ECG,

plethysmographic, and capnographic traces as well as derived HR, SpO

2

, NIBP, and

etCO

2

. The observer recorded the total time of colonoscopy, drugs (type, dosage, and

time of administration), and time from the end of the procedure until OAA/S > 4, any

cardiorespiratory events, and all actions taken to prevent or treat these problems (e.g. chin

lift/jaw thrust, stimulation of the patient, or temporary mask ventilation).

As significant events were considered: decline in SpO

2

< 90%, respiratory rate < 6/min,

increase of etCO

2

> 50 mmHg; change in HR to +20% of baseline or occurrence of any

arrhythmia’s; and systolic NIBP +20 % of the first NIBP measurement.

Recovery

After colonoscopy, patients had to stay at least 1 h in the recovery room. Monitoring

included SpO

2

, ECG, and NIBP. The modified Aldrete score

12

was recorded on arrival in the

recovery area, after 30 min and 1 h. It describes patient`s motor activity, respiratory function,

SpO

2

, NIBD, and consciousness, and is designed to assess patient recovery. The total score